Personalized psychiatry: a realistic goal

Area of Science:

• Genetics
• Psychiatry
• Pharmacotherapy

Background:

• The human genome project completion in 2001 sparked widespread anticipation for personalized medicine.
• Initial media coverage predicted rapid, revolutionary changes in clinical practice.
• Subsequent discoveries revealed significant human genome variation complexity.

Purpose of the Study:

• To assess the realistic timeline for personalized medicine implementation.
• To explore the potential for personalized medicine in psychiatry.
• To identify near-term benefits of genetic profiling in psychiatric pharmacotherapy.

Main Methods:

• Review of scientific literature and media commentary.
• Analysis of human genome variation data.
• Evaluation of psychiatric pharmacotherapy advancements.

Main Results:

• True personalized medicine faces decades-long implementation challenges for many fields.
• Psychiatry shows more immediate potential for personalized medicine elements.
• Genetic patient profiling for psychiatric pharmacotherapy may offer near-term benefits.

Conclusions:

• Widespread personalized medicine is not imminent due to genomic complexity.
• Psychiatry may be an early adopter of personalized medicine principles.
• Genetic insights could soon enhance psychiatric treatment personalization.